Ritter P M, Marti A, Blanc C, Baltzer A, Krajewski S, Reed J C, Jaggi R
Department for Clinical Research, University of Bern, Switzerland.
Eur J Cell Biol. 2000 May;79(5):358-64. doi: 10.1078/S0171-9335(04)70040-0.
Caspases are aspartate-specific proteases that are specifically activated by numerous death stimuli. Caspase activation is thought to play a major role for the execution of apoptosis. Inactive caspase-9 zymogen is known to be localized within the mitochondrial intermembrane space where it is involved in monitoring mitochondrial damage-associated cytochrome c release and subsequent activation of procaspase-3. Here we show that in mammary epithelial cell lines a significant fraction of caspase-9 proform is associated with discrete structures in the nucleus. Stimulation of cells with chemotherapeutic agents leads to the processing of nuclear procaspase-9 and to the accumulation of nuclear and cytoplasmic caspase activity. Using cell-free extracts from caspase-3-deficient MCF-7 cells we show that caspase-8-mediated processing of nuclear procaspase-9 requires caspase-3. In caspase-3-expressing breast cancer cells, cytochrome c-induced processing of nuclear procaspase-9 is blocked by the caspase inhibitors z-VAD and DEVD but not by YVAD. Purified active caspase-3 is sufficient to cleave nuclear caspase-9 zymogen. These results suggest that, in addition to the mitochondrial localization, caspase-9 proform is found within the nucleus and its processing can be regulated by caspase-3.
半胱天冬酶是天冬氨酸特异性蛋白酶,可被多种死亡刺激特异性激活。半胱天冬酶的激活被认为在细胞凋亡的执行中起主要作用。已知无活性的半胱天冬酶-9酶原定位于线粒体内膜间隙,在那里它参与监测线粒体损伤相关的细胞色素c释放以及随后的半胱天冬酶原-3激活。在这里,我们表明,在乳腺上皮细胞系中,相当一部分半胱天冬酶-9前体与细胞核中的离散结构相关。用化疗药物刺激细胞会导致细胞核内半胱天冬酶原-9的加工以及细胞核和细胞质半胱天冬酶活性的积累。使用来自缺乏半胱天冬酶-3的MCF-7细胞的无细胞提取物,我们表明半胱天冬酶-8介导的细胞核半胱天冬酶原-9的加工需要半胱天冬酶-3。在表达半胱天冬酶-3的乳腺癌细胞中,细胞色素c诱导的细胞核半胱天冬酶原-9的加工被半胱天冬酶抑制剂z-VAD和DEVD阻断,但不被YVAD阻断。纯化的活性半胱天冬酶-3足以切割细胞核半胱天冬酶-9酶原。这些结果表明,除了线粒体定位外,半胱天冬酶-9前体还存在于细胞核中,其加工可由半胱天冬酶-3调节。